X

AggregoTV

Top Videos
ESMO Vision stories of Integrated Cancer Care: Verna Vanderpuye, Ghana

"I think ESMO is poised to do that and I think we have a bright future ahead of us," says ESMO member Verna Vanderpuye from Ghana.

10/23/2020
What is the Evidence that Fecal Microbiota Transplantation Can Cure GvHD?

Mette Hazenberg, Amsterdam UMC discusses evidence that fecal microbiota transplantation can cure GvHD.

12/14/2020

AggregoTV

Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz

Dr. Scott Kopetz discusses the latest breakthroughs and future promise of immunotherapy for colorectal cancer patients.

12/11/2020
ESMO Vision Stories of Sustainable Cancer Care: Andrea Sbrana

Is statistically significant the same as clinically significant? The ESMO-MCBS has been thought to try and answer this question even when talking about newer treatments, explains Andrea Sbrana.

12/17/2020
Leukemia, Lymphoma, Myeloma, and Immunotherapy with Dr. Philip Greenberg

Dr. Philip Greenberg discusses how immunotherapy works for blood cancers, promising immunotherapy clinical trials, as well as potential side effects.

12/11/2020
What is the Evidence that Fecal Microbiota Transplantation Can Cure GvHD?

Mette Hazenberg, Amsterdam UMC discusses evidence that fecal microbiota transplantation can cure GvHD.

12/14/2020
Pancreatic Cancer and Immunotherapy with Dr. Elizabeth M. Jaffee

Join Dr. Elizabeth Jaffee of the Bloomberg~Kimmel Institute for Cancer Immunotherapy for a Q&A discussion about immunotherapies in clinical trials for pancreatic cancer.

12/11/2020
`

AggregoTV - AML

An update on the NCRI AML20 trial

Charles Craddock describes the three main questions the trial aims to address, including whether the addition of venetoclax can improve the activity of CPX-351 in adults with AML.

10/21/2020
What Are the Goals of AML Treatment?

Dr. Pinkal Desai defines the role of remission and the specific goals of treatment for AML patients.

11/19/2020
High Dose Therapy and Autologous Stem Cell Transplantation
red blood cells

Discussion on high dose therapy and autologous stem cell transplantation.

What is new in targeted therapies for AML?

Dr. Navel Daver discusses the use of single agents, such as the FLT3 inhibitor, gilteritinib, and the IDH1 inhibitor, ivosidenib, as well as the outcomes of more recent combination treatments with

10/19/2020
Understanding Risk in AML: How Molecular Testing Affects Treatment Options

How does molecular testing impact AML treatment options? Dr. Pinkal Desai discusses molecular testing and how results may help determine the best treatment path for patients.

11/19/2020

AggregoTV - NSCLC

What Are The Symptoms of NSCLC?

 

The symptoms of non-small cell lung cancer are not specific. Learn more here about the possible symptoms. 

03/05/2021
Radiosurgery Followed by Tumor-Treating Fields for NSCLC Brain Metastases

Dr Minesh P Mehta discusses radiosurgery followed by tumor-treating fields for NSCLC brain metastases.

12/12/2020
Improving the Staging and Diagnosis of Patients With Stage III/IV Non-Small Cell Lung Cancer

Findings for Pathology and Pulmonary Medicine From a National Quality Survey, presented at the CAP 2020 Virtual Meeting.

11/10/2020
Expert Video Report on Lung Cancer From ASCO 2020

Reporting remotely on findings presented at ASCO 2020 Virtual Meeting, Egbert Smit comments on important and potentially practice changing study results in NSCLC.

06/09/2020
Pembrolizumab for Non-Small Cell Lung Cancer Associated Brain Metastases

Dr Sarah B. Goldberg discusses the use of pembrolizumab for non-small cell lung cancer associated brain metastases.

12/16/2020
Motivating Stage III NSCLC Patients to Stay on Treatment

Oncology specialists from a lung multidisciplinary team discuss best practices on motivating patients to stay on therapy.

11/25/2020

AggregoTV - DLBCL

New Models for NHL Care: Innovative Therapy in FL and DLBCL

Dr Nathan H. Fowler, Dr Martin Dreyling, Dr Caron Jacobson and Dr Krish Patel discuss non-Hodgkin lymphoma in this CME activity titled Building New Management Models for NHL Care...

03/04/2021
CAR-T Moving Forwards for R/R DLBCL

Dr Anna Sureda gives an overview of first line therapies and the role of stem cell transplantation and CAR-T therapy in the treatment of DLBCL.

03/22/2021
Mosunetuzumab for Chemotherapy-Intolerant DLBCL

Dr Adam Olszewski shares the preliminary results of the ongoing Phase I/II trial assessing the safety and efficacy of mosunetuzumab in patients with DLBCL who are intolerant to chemotherapy.

12/14/2020
New Options When DLBCL Doesn’t Respond to Treatment

Linda Bohannon interviews Dr Kami Maddocks about the newest treatments for relapsed/refractory DLBCL.

02/23/2021
ZUMA-9: Expanded Access Protocol and OOS Axicabtagene Ciloleucel in R/R DLBCL

Dr Frederick Locke outlines the results of the ZUMA-9 trial of out-of-specification or expanded access to axicabtagene ciloleucel (axi-cel) in relapsed/refractory large B-cell lymphoma patients.

12/06/2020
Real-World Efficacy & Safety Data: CAR-T in DLBCL

Dr Matthew Frigault comments on the key clinical trials involved in CAR T-cell therapy for the treatment of refractory DLBCL including results from ZUMA-1, JULIET, and TRANSCEND studies.

08/30/2020
Spotlight
Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz

Dr. Scott Kopetz discusses the latest breakthroughs and future promise of immunotherapy for colorectal cancer patients.

12/11/2020

source list reference

#7d60d9
#2694a4
#32a887
#85eb24
#352625
#4d4537
#d2093c
#8e3f1c
#76b6c3
#bfcfc8
#c61417
#67e25b
#efef71
#03cffc
#42fc9a
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
#e7f6e3
#9a8c2c
#a9c507
#2b9ab3
#e61923
#990677
#4a7bab
#89f67c
#49a21d
#2c990a
#d7da81
#575662
#a60538
#49cde9
#c20fce
#d95d39